Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence

AIMS: To evaluate the efficacy and safety of the PROMETA™ Protocol for treating methamphetamine dependence. DESIGN: A double-blind, placebo-controlled 108-day study with random assignment to one of two study conditions: active medication with flumazenil (2 mg infusions on days 1, 2, 3, 22, 23), gaba...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Ling, Walter, Shoptaw, Steven, Hillhouse, Maureen, Bholat, Michelle A., Charuvastra, Charles, Heinzerling, Keith, Chim, David, Annon, Jeffrey, Dowling, Patrick T., Doraimani, Geetha
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2011
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122522/
https://ncbi.nlm.nih.gov/pubmed/22082089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1360-0443.2011.03619.x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन